Tofajak In Xr 11mg Tablets

Specifications

Dosage Type

Tablet

Salt composition

Tofacitinib(11.0 mg)

Packaging

Strip

Storage Tips

Store in a cool and dry place away from direct sunlight., Keep away from children and pets.

Safety Advice

Alcohol: Safe - Consuming Alcohol With Tofajak-In Xr 11Mg Tablet Does Not Cause Any Harmful Side Effects. Pregnancy: Consult Your Doctor - Tofajak-In Xr 11Mg Tablet May Be Unsafe To Use During Pregnancy. Although There Are Limited Studies In Humans, Animal Studies Have Shown Harmful Effects On The Developing Baby. Your Doctor Will Weigh The Benefits And Any Potential Risks Before Prescribing It To You. Please Consult Your Doctor. Breast feeding: Consult Your Doctor - Tofajak-In Xr 11Mg Tablet Is Probably Unsafe To Use During Breast feeding. Limited Human Data Suggests That The Drug May Pass Into The Breastmilk And Harm The Baby. Driving: Safe - Tofajak-In Xr 11Mg Tablet Does Not Usually Affect Your Ability To Drive. Kidney: Caution - Tofajak-In Xr 11Mg Tablet Should Be Used With Caution In Patients With Severe Kidney Disease. Dose Adjustment Of Tofajak-In Xr 11Mg Tablet May Be Needed. Please Consult Your Doctor. Liver: Caution - Tofajak-In Xr 11Mg Tablet Should Be Used With Caution In Patients With Severe Liver Disease. Dose Adjustment Of Tofajak-In Xr 11Mg Tablet May Be Needed. Please Consult Your Doctor.

Side Effects

Diarrhea, Upper Respiratory Tract Infection, Headache

Interaction with Drugs

Drug: Herpes Zoster / Shingles Vaccine (Recombinant, Adjuvanted) (Injection Route) Description: Do not use Tofacitinib with Herpes Zoster / Shingles Vaccine (Recombinant, Adjuvanted). Concurrent use may increase the risk of infections. Drug: Carbamazepine (Oral Route) Description: Do not consume Tofacitinib with Carbamazepine. Carbamazepine may reduce blood levels of Tofacitinib. Concurrent use may result in loss of efficacy of Tofacitinib. Drug: Fosphenytoin (Injection Route) Description: Do not consume Tofacitinib with Fosphenytoin. Fosphenytoin may reduce blood levels of Tofacitinib. Concurrent use may result in loss of efficacy of Tofacitinib. Drug: Bosentan (Oral Route) Description: Do not consume Tofacitinib with Bosentan. Bosentan may reduce blood levels of Tofacitinib. Drug: Cholera Vaccine (Inactivated) (Oral Route) Description: Do not use Tofacitinib with Cholera Vaccine (Inactivated). Concurrent use may increase the risk of infections.